Chunlong Zhao

476 total citations
22 papers, 373 citations indexed

About

Chunlong Zhao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Chunlong Zhao has authored 22 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Chunlong Zhao's work include Peptidase Inhibition and Analysis (9 papers), Histone Deacetylase Inhibitors Research (9 papers) and Protein Degradation and Inhibitors (8 papers). Chunlong Zhao is often cited by papers focused on Peptidase Inhibition and Analysis (9 papers), Histone Deacetylase Inhibitors Research (9 papers) and Protein Degradation and Inhibitors (8 papers). Chunlong Zhao collaborates with scholars based in China, United States and Netherlands. Chunlong Zhao's co-authors include Yingjie Zhang, Hang Dong, Frank J. Dekker, C. James Chou, Wenfang Xu, Deng Chen, Hao Yin, Jie Zang, Guozhen Zhang and Shunda Li and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and Advanced Science.

In The Last Decade

Chunlong Zhao

21 papers receiving 368 citations

Peers

Countries citing papers authored by Chunlong Zhao

Since Specialization

Citations

This map shows the geographic impact of Chunlong Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlong Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlong Zhao more than expected).

Fields of papers citing papers by Chunlong Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlong Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlong Zhao. The network helps show where Chunlong Zhao may publish in the future.

Co-authorship network of co-authors of Chunlong Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlong Zhao. A scholar is included among the top collaborators of Chunlong Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlong Zhao. Chunlong Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent progress of small molecular HDAC modulators for cancer therapy and beyond 2025 ·Chunlong Zhao, (unknown), Yingjie Zhang	0
2	Small Molecule MIF Modulation Enhances Ferroptosis by Impairing DNA Repair Mechanisms 2024 ·Advanced Science ·Deng Chen, Chunlong Zhao, Jianqiu Zhang, (unknown), (unknown), (unknown), (unknown), Zhangping Xiao, (unknown), Andrew J. Griffith, (unknown), (unknown), Robert P. Coppes, Amalia M. Dolga, Hidde J. Haisma, Frank J. Dekker	7
3	Multi-Objective Optimization Design of the Small Flow Rate Emitter Structure Based on the NSGA-II Genetic Algorithm 2024 ·Agriculture ·(unknown), Yan Mo, Chunlong Zhao, (unknown), Yanqun Zhang, Juan Xiao, Shihong Gong, (unknown)	1
4	Discovery of highly potent HDAC8 PROTACs with anti-tumor activity 2023 ·Bioorganic Chemistry ·Chunlong Zhao, Deng Chen, Feng‐Zhi Suo, Rita Setroikromo, Wim J. Quax, Frank J. Dekker	21
5	Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity 2023 ·Journal of Medicinal Chemistry ·Fengling Liu, Chunxi Liu, (unknown), Chunlong Zhao, Hongwei Meng, Xue Xia, Tso‐Pang Yao, Yingjie Zhang	13
6	Discovery of Highly Potent Hdac8 Protacs with Anti-Tumor Activity 2023 ·SSRN Electronic Journal ·Chunlong Zhao, Deng Chen, Feng‐Zhi Suo, Rita Setroikromo, Wim J. Quax, Frank J. Dekker	1
7	Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras 2022 ·ACS Pharmacology & Translational Science ·Chunlong Zhao, Frank J. Dekker	22
8	HDAC/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway 2021 ·Bioorganic Chemistry ·Fangyuan Cao, Zhangping Xiao, Siwei Chen, Chunlong Zhao, Deng Chen, Hidde J. Haisma, Frank J. Dekker	18
9	Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity 2021 ·Bioorganic Chemistry ·Shunda Li, Chunlong Zhao, Guozhen Zhang, (unknown), Qian Liu, Wei Zhao, C. James Chou, Yingjie Zhang	18
10	Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis 2021 ·RSC Advances ·(unknown), Chunlong Zhao, Hang Dong, (unknown), Yingjie Zhang	4
11	Synthesis and biological study of class I selective HDAC inhibitors with NO releasing activity 2020 ·Bioorganic Chemistry ·(unknown), Chunxi Liu, Chunlong Zhao, Hang Dong, (unknown), C. James Chou, Yingjie Zhang	7
12	MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level 2020 ·Experimental and Molecular Pathology ·(unknown), Chunlong Zhao, (unknown), (unknown), (unknown)	5
13	Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present) 2020 ·Expert Opinion on Therapeutic Patents ·Chunlong Zhao, Hang Dong, (unknown), Yingjie Zhang	108
14	In vivo pharmacokinetic study and oral glucose tolerance test of sulfoxide analogs of GPR40 agonist TAK‐875 2020 ·Drug Development Research ·(unknown), (unknown), Chunlong Zhao, Hang Dong, Wenfang Xu, Yingjie Zhang	3
15	Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II 2019 ·Bioorganic & Medicinal Chemistry ·(unknown), Jie Zang, (unknown), Chunlong Zhao, Ting Chen, Yingying Ran, Hang Dong, Wenfang Xu, Yingjie Zhang	10
16	Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors 2019 ·Molecules ·Hang Dong, Hao Yin, Chunlong Zhao, (unknown), Wenfang Xu, Yingjie Zhang	37
17	Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors 2018 ·European Journal of Medicinal Chemistry ·Chunlong Zhao, Jie Zang, (unknown), Elizabeth S. Inks, Wenfang Xu, C. James Chou, Yingjie Zhang	31
18	Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry 2018 ·Bioorganic & Medicinal Chemistry ·(unknown), Chunhua Ma, Jie Zang, Shuai Gao, (unknown), (unknown), (unknown), Xuewu Liang, (unknown), Chunlong Zhao, Binghe Wang, Wenfang Xu, Yingjie Zhang	10
19	Effects of Selenium on the Antioxidant Enzymes Response of Neocaridina heteropoda Exposed to Ambient Nitrite 2009 ·Bulletin of Environmental Contamination and Toxicology ·(unknown), Haiming Xu, Guohua Xiao, Chunlong Zhao, (unknown), (unknown), Hongquan Li, (unknown)	15
20	Effects of Selenium on the Activity of Antioxidant Enzymes in the Shrimp, Neocaridina heteropoda 2009 ·Israeli Journal of Aquaculture - Bamidgeh ·Yueqiang Guan, Zihui Wang, Guohua Xiao, Haiming Xu, Chunlong Zhao, (unknown), (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact